Summit Therapeutics Inc. (SMMT)
BMV
290.12
0.00 (0.00%)
Closed
Oct 7, 2026
Day's Range
290.12290.12
52 wk Range
281.00430.00
Financial Statements - SMMT - Summit Therapeutics Inc.
Revenue
0
Net Income
-1.07B▲ 71.7%
EBITDA
-1.09B▲ 67.8%
Free Cash Flow
-323.58M▲ 86.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 705K | 1.80M | 860K |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -1.09B | -3.63B | -609.68M | -67.07M | -86.17M | -52.30M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 14.83M | -260.23M | 780K | -12.27M | -2.17M | -325K |
| Pre Tax Income | -1.07B | -3.81B | -614.96M | -82.23M | -88.60M | -52.91M |
| Income Tax | - | - | - | - | 0 | -213K |
| Net Income | -1.07B | -3.81B | -614.96M | -82.23M | -88.60M | -52.69M |
| EPS Basic | -1.44 | -0.31 | -0.99 | -0.41 | -0.96 | -0.76 |
| EPS Diluted | -1.44 | -0.31 | -0.99 | -0.41 | -0.96 | -0.76 |
| Basic Shares Outstanding | 747.70M | 12.38B | 30.32M | 9.46M | 4.51M | 3.39M |
| Diluted Shares Outstanding | 747.70M | 12.38B | 30.32M | 9.46M | 4.51M | 3.39M |
| Ebit | -1.07B | -3.66B | -598.50M | -77.83M | -88.36M | -52.65M |
| Ebitda | -1.09B | -3.40B | -599.33M | -63.99M | -83.77M | -49.84M |
| Net Income Continuous Operations | -1.07B | -3.81B | -614.92M | -78.78M | -88.60M | -52.69M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
